| Literature DB >> 35712622 |
Jesús Rodríguez-López1, Javier De la Cruz Bértolo2, Nadia Raquela García-Lara1, Izaskun Asla Elorriaga3, Lourdes Román Echevarría3, Máximo Vento4, Anna Parra-Llorca4, Fernando Cabañas5, Pedro Lozano5, Óscar García-Algar6, Ana Martín-Ancel7, Cristina Copons Fernández8, Ersilia González Carrasco9, Iciar Olabarrieta Arnal9, Adelina Pellicer10, Natalia Marín Huarte10, Carmen Rosa Pallás-Alonso1.
Abstract
Background: During early skin-to-skin contact (ESSC), alterations in peripheral oxygen saturation (SpO2) and heart rate (HR) have been frequently observed.Entities:
Keywords: cardiorespiratory events; early skin-to-skin contact; healthy term newborns; oxygen desaturation; oxygen saturation monitoring; prognostic factor; pulse oximetry; sudden unexpected postnatal collapse (SUPC)
Year: 2022 PMID: 35712622 PMCID: PMC9194510 DOI: 10.3389/fped.2022.907570
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.569
FIGURE 1Study flow diagram. Eligibility and post-randomization exclusion criteria. Participants with and without outcome. CRE, cardiorespiratory event.
Maternal characteristics: association with cardiorespiratory event (univariable analysis).
| Variables | CRE | No CRE | Odds ratio (95% CI) | |
| Age ≥35 years | 83/169 (49) | 33/85 (39) | 1.52 (0.89–2.58) | 0.121 |
| Country of birth, Spain | 109/168 (65) | 55/85 (65) | 1.00 (0.58–1.74) | 0.978 |
| Relevant medical history | 49/163 (30) | 31/83 (37) | 0.72 (0.41–1.26) | 0.249 |
| Primiparous | 67/168 (40) | 24/84 (29) | 0.60 (0.34–1.06) | 0.078 |
| Previous child who died in the first year of life | 1/168 (0.6) | 1/84 (1) | 0.49 (0.03–8.05) | 0.616 |
| Intention to breastfeed | 162/169 (96) | 75/84 (89) | 2.78 (0.99–7.74) | 0.043 |
| Gestational BMI >25 Kg/m2 | 95/133 (71) | 47/81 (58) | 1.81 (1.01–3.23) | 0.045 |
| Medication consumption during 72 h prior to delivery | 22/166 (13) | 27/84 (32) | 0.32 (0.17–0.61) | <0.001 |
| Non-opioid analgesics/anti-inflammatory drugs | 6/166 (4) | 9/84 (11) | ||
| Thyroid hormone | 4/166 (2) | 10/84 (12) | ||
| Ranitidine/almagate | 3/166 (2) | 7/84 (8) | ||
| Other medications | 10/166 (6) | 4/84 (5) | ||
| Induction of labor | 37/168 (22) | 17/85 (20) | 0.88 (0.46–1.69) | 0.711 |
| Epidural analgesia | 134/169 (79) | 75/85 (88) | 0.51 (0.24–1.09) | 0.078 |
| Rupture of membranes (<18 h) | 151/169 (89) | 77/84 (92) | 1.31 (0.53–3.27) | 0.561 |
| Duration of delivery (<16 h) | 160/165 (97) | 76/78 (97) | 1.19 (0.23–6.26) | 0.839 |
| Maternal medication during labor and 2 h afterward | 30/165 (18) | 17/81 (21) | 0.86 (0.45–1.67) | 0.663 |
CRE, cardiorespiratory event; CI, confidence interval; BMI, body mass index.
Neonatal characteristics: association with cardiorespiratory event (univariable analysis).
| Variables | CRE | No CRE | Odds ratio (95% CI) | |
| Gestational age 37–38 versus 39–41 weeks | 46/169 (27) | 30/85 (35) | 0.69 (0.39–1.19) | 0.185 |
| Birth time between 09:00 p.m. and 08:59 a.m. | 36/169 (21) | 9/85 (11) | 0.44 (0.20–0.96) | 0.035 |
| ≥1 nuchal cord | 41/168 (24) | 21/83 (25) | 0.95 (0.52–1.75) | 0.877 |
| Male | 84/169 (50) | 41/84 (49) | 1.04 (0.61–1.75) | 0.893 |
| 1-min Apgar score 8 versus 9–10 | 34/169 (20) | 19/85 (22) | 0.87 (0.46–1.65) | 0.679 |
| 5-min Apgar score 9 versus 10 | 26/169 (15) | 8/85 (9) | 0.57 (0.25–1.32) | 0.188 |
| Birth weight <3,000 versus ≥3,000 g | 121/169 (72) | 60/84 (71) | 0.99 (0.56–1.77) | 0.977 |
CRE, cardiorespiratory event; CI, confidence interval.
FIGURE 2Factors associated with cardiorespiratory events (multivariate logistic regression analysis). Gestational BMI >25, gestational body mass index >25 Kg/m2.